Aptinyx Inc. (APTX) OTC MARKETS

$0.06 - (-)

Market Cap: -

As of 05/18/23 12:00 AM EDT. Market closed.

(APTX)

Aptinyx Inc. (APTX)
OTC MARKETS

$0.06
- (-)

Market Cap: -

As of 05/18/23 12:00 AM EDT. Market closed.

Add to Portfolio

welcome to our company page and thank you for your interest in aptinyx inc. aptinyx is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. aptinyx has a proven platform for discovering proprietary compounds that work through a novel mechanism: modulation of the nmda receptor to enhance pathways involved with nerve ... read more

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$452,509
CEO Compensation (Total)
$10.61M
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$452,509
CEO Compensation (Total)
$10.61M
Address
.
PRICE CHART FOR APTINYX INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.10
Previous Close
$0.06
Days Range
$0.06 - $0.11
52 week range
- - -
Volume
7,805,028
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
67,715,718
Open
$0.10
Previous Close
$0.06
Days Range
$0.06 - $0.11
52 week range
- - -
Volume
7,805,028
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
67,715,718
FINANCIAL STATEMENTS FOR APTINYX INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR APTINYX INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Miller Joan W.DirectorJan 13, 2022 Buy$2.8317,70050,09117,700Jan 18, 2022, 04:19 PM
RIEDEL NORBERT GCEODec 06, 2021 Buy$2.23100,000223,000100,000Dec 08, 2021, 04:16 PM
KHANNA ASHISHCFO AND CBODec 02, 2021 Buy$2.2645,000101,700420,040Dec 06, 2021, 04:16 PM
HOMBACH ROBERT J.DirectorNov 11, 2021 Buy$2.405,40012,960154,500Nov 16, 2021, 05:58 PM
HOMBACH ROBERT J.DirectorNov 12, 2021 Buy$2.4074,600179,040229,100Nov 16, 2021, 05:58 PM
HOMBACH ROBERT J.DirectorNov 12, 2021 Buy$2.4074,600179,040219,100Nov 15, 2021, 06:37 PM
HOMBACH ROBERT J.DirectorNov 11, 2021 Buy$2.405,40012,960144,500Nov 15, 2021, 06:37 PM
RIEDEL NORBERT GCEOMay 17, 2021 Option Exercise$2.53127,274322,003615,265May 19, 2021, 06:46 PM
Bain Capital Life Sciences Investors, LLC10% OwnerOct 26, 2020 Buy$3.003,333,3339,999,9998,891,758Oct 27, 2020, 05:07 PM
Topper James NDirectorMar 31, 2020 Option Exercise$2.164,97610,7483,195,055Apr 02, 2020, 04:32 PM
Sherman Rachel E.DirectorJan 22, 2020 Buy$4.792,17410,4132,174Jan 23, 2020, 05:44 PM
Koppel AdamDirectorJan 14, 2020 Buy$3.003,333,3339,999,9995,558,425Jan 16, 2020, 04:20 PM
ADAMS STREET PARTNERS LLC10% OwnerJan 10, 2020 Buy$3.001,000,0003,000,0001,465,716Jan 14, 2020, 05:05 PM
RIEDEL NORBERT GCEO and PresidentJan 10, 2020 Buy$3.0035,000105,00035,000Jan 14, 2020, 04:23 PM
HOMBACH ROBERT J.DirectorJan 10, 2020 Buy$3.0050,000150,000139,100Jan 14, 2020, 04:21 PM
Gosebruch Henry ODirectorJan 10, 2020 Buy$3.0025,00075,000125,000Jan 14, 2020, 04:19 PM
ENRIGHT PATRICK GDirectorJan 10, 2020 Buy$3.0095,000285,00095,000Jan 14, 2020, 04:16 PM
ENRIGHT PATRICK GDirectorJan 10, 2020 Buy$3.00166,667500,0013,356,746Jan 14, 2020, 04:16 PM
HOMBACH ROBERT J.DirectorNov 22, 2019 Buy$3.2350,000161,75089,100Nov 26, 2019, 04:12 PM
Gosebruch Henry ODirectorMay 08, 2019 Buy$3.8696,580372,799100,000May 09, 2019, 10:01 AM
Gosebruch Henry ODirectorMay 07, 2019 Buy$3.753,42012,8253,420May 09, 2019, 10:01 AM
Madsen Torsten M.Chief Medical OfficerJan 28, 2019 Buy$5.271,0505,533232,600Jan 30, 2019, 06:58 PM
HOMBACH ROBERT J.DirectorJan 24, 2019 Buy$5.5213,34573,66437,445Jan 28, 2019, 06:12 PM
HOMBACH ROBERT J.DirectorJan 25, 2019 Buy$5.5411,65564,56949,100Jan 28, 2019, 06:12 PM
KHANNA ASHISHCFO and CBOJan 18, 2019 Buy$5.4510,00054,500283,130Jan 18, 2019, 08:38 PM
RIEDEL NORBERT GCEO and PresidentNov 12, 2018 Option Exercise$2.5938,56399,878362,539Nov 14, 2018, 04:16 PM
New Leaf Venture Management III, L.L.C.10% OwnerJun 25, 2018 Buy$16.00250,0004,000,0002,921,734Jun 26, 2018, 04:57 PM
Frazier Life Sciences VIII, L.P.10% OwnerJun 25, 2018 Buy$16.00150,0002,400,0003,190,079Jun 26, 2018, 04:56 PM
HOMBACH ROBERT J.DirectorJun 25, 2018 Buy$16.0024,100385,60024,100Jun 26, 2018, 04:55 PM
Longitude Capital Partners II, LLC10% OwnerJun 25, 2018 Buy$16.00150,0002,400,0003,190,079Jun 26, 2018, 04:55 PM
Topper James NDirectorJun 25, 2018 Buy$16.00150,0002,400,0003,190,079Jun 26, 2018, 04:54 PM
Ratcliffe LiamDirectorJun 25, 2018 Buy$16.00250,0004,000,0002,921,734Jun 26, 2018, 04:53 PM
Koppel AdamDirectorJun 25, 2018 Buy$16.00400,0006,400,0002,225,092Jun 26, 2018, 04:50 PM
Gould Terry PDirectorJun 25, 2018 Buy$16.00150,0002,400,0001,115,910Jun 26, 2018, 04:50 PM
ENRIGHT PATRICK GDirectorJun 25, 2018 Buy$16.00150,0002,400,0003,190,079Jun 26, 2018, 04:49 PM
GANTZ WILBUR HDirectorJun 25, 2018 Buy$16.0023,100369,600372,514Jun 26, 2018, 04:49 PM
MOSKAL JOSEPH R.Chief Scientific OfficerJun 25, 2018 Buy$16.003,00048,000378,288Jun 26, 2018, 04:47 PM
Madsen Torsten M.Chief Medical OfficerJun 25, 2018 Buy$16.001,00016,000231,550Jun 26, 2018, 04:47 PM
KIDD ANDREWChief Commercial OfficerJun 25, 2018 Buy$16.006,700107,2009,133Jun 26, 2018, 04:45 PM
KHANNA ASHISHCFO and CBOJun 25, 2018 Buy$16.001,80028,8001,800Jun 26, 2018, 04:44 PM
KHANNA ASHISHCFO and CBOJun 25, 2018 Buy$16.006,00096,000273,130Jun 26, 2018, 04:44 PM
RIEDEL NORBERT GCEO and PresidentJun 25, 2018 Buy$16.002,40038,4005,118Jun 26, 2018, 04:44 PM
ADAMS STREET PARTNERS LLC10% OwnerJun 25, 2018 Buy$16.00150,0002,400,0001,115,910Jun 26, 2018, 04:44 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Miller Joan W.Director01/13/202250,091
RIEDEL NORBERT GCEO12/06/2021223,000
KHANNA ASHISHCFO AND CBO12/02/2021101,700
HOMBACH ROBERT J.Director11/11/202112,960
HOMBACH ROBERT J.Director11/12/2021179,040
HOMBACH ROBERT J.Director11/12/2021179,040
HOMBACH ROBERT J.Director11/11/202112,960
RIEDEL NORBERT GCEO05/17/2021322,003
Bain Capital Life Sciences Investors, LLC10% Owner10/26/20209,999,999
Topper James NDirector03/31/202010,748
Sherman Rachel E.Director01/22/202010,413
Koppel AdamDirector01/14/20209,999,999
ADAMS STREET PARTNERS LLC10% Owner01/10/20203,000,000
RIEDEL NORBERT GCEO and President01/10/2020105,000
HOMBACH ROBERT J.Director01/10/2020150,000
Gosebruch Henry ODirector01/10/202075,000
ENRIGHT PATRICK GDirector01/10/2020285,000
ENRIGHT PATRICK GDirector01/10/2020500,001
HOMBACH ROBERT J.Director11/22/2019161,750
Gosebruch Henry ODirector05/08/2019372,799
Gosebruch Henry ODirector05/07/201912,825
Madsen Torsten M.Chief Medical Officer01/28/20195,533
HOMBACH ROBERT J.Director01/24/201973,664
HOMBACH ROBERT J.Director01/25/201964,569
KHANNA ASHISHCFO and CBO01/18/201954,500
RIEDEL NORBERT GCEO and President11/12/201899,878
New Leaf Venture Management III, L.L.C.10% Owner06/25/20184,000,000
Frazier Life Sciences VIII, L.P.10% Owner06/25/20182,400,000
HOMBACH ROBERT J.Director06/25/2018385,600
Longitude Capital Partners II, LLC10% Owner06/25/20182,400,000
Topper James NDirector06/25/20182,400,000
Ratcliffe LiamDirector06/25/20184,000,000
Koppel AdamDirector06/25/20186,400,000
Gould Terry PDirector06/25/20182,400,000
ENRIGHT PATRICK GDirector06/25/20182,400,000
GANTZ WILBUR HDirector06/25/2018369,600
MOSKAL JOSEPH R.Chief Scientific Officer06/25/201848,000
Madsen Torsten M.Chief Medical Officer06/25/201816,000
KIDD ANDREWChief Commercial Officer06/25/2018107,200
KHANNA ASHISHCFO and CBO06/25/201828,800
KHANNA ASHISHCFO and CBO06/25/201896,000
RIEDEL NORBERT GCEO and President06/25/201838,400
ADAMS STREET PARTNERS LLC10% Owner06/25/20182,400,000
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR APTINYX INC
LOADING...